Kiniksa Pharmaceuticals International, plc
KNSA
$56.51
-$2.03-3.47%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
MarketBeat
5/12/2026
-
The Cerbat Gem
5/11/2026
-
MarketBeat
5/6/2026
-
Simply Wall St
5/5/2026
-
MarketBeat
5/5/2026
-
MarketBeat
5/5/2026
-
Simply Wall St
5/4/2026
-
MarketBeat
5/4/2026
-
MarketBeat
5/1/2026
-
TipRanks Financial Blog
5/1/2026
-
MarketBeat
5/1/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
Simply Wall St
4/30/2026
-
MarketBeat
4/30/2026
-
MarketBeat
4/30/2026
-
Tickeron - Stocks
4/29/2026
-
Ticker Report
4/29/2026
-
MarketBeat
4/29/2026
-
MarketBeat
4/29/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 28, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Jul 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 78 1431 9100
Address
105 Piccadilly
London, W1J 7NJ
London, W1J 7NJ
Country
Year Founded
Business Description
Sector
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company...
more